NAD+ IV therapy claims: what the evidence actually supports

What did @rana.good actually say?

She described getting an NAD+ IV infusion, felt "disoriented and nauseous" during it, and theorized the rough experience happens because NAD+ is "interacting with the mitochondria." Afterward she reported sleeping better and feeling more alert, but wasn't sure those benefits were worth repeating the experience. She framed NAD+ IV as "the fountain of youth," which is the claim doing the heaviest lifting here.

To be fair, she's being honest about her experience rather than selling you on a product. She's skeptical of her own results. That's more than most wellness influencers offer. But the "fountain of youth" framing and the mitochondria explanation both deserve scrutiny, because one is marketing copy and the other is a partial truth stretched to explain something more complicated.

Does the science back this up?

The side effects she described are real and documented. The mitochondria explanation is roughly correct but incomplete. The "fountain of youth" framing is not supported by current evidence in humans.

NAD+ is a coenzyme involved in cellular energy metabolism, DNA repair, and signaling pathways linked to aging in animal models. That part is legitimate. Intravenous NAD+ infusions do cause notable side effects, including nausea, chest tightness, flushing, and that hard-to-describe sense of dysphoria she compared to falling off a bike. A 2020 review by Mehmel et al. in Nutrients confirmed these infusion-related symptoms are common and likely related to the speed of cellular uptake, particularly in tissues with high metabolic demand. The mitochondrial connection is real, but the mechanism isn't fully characterized in humans.

The longevity benefits are a different story. Most of the dramatic NAD+ data comes from mouse studies. Human clinical trials are small, short, and haven't shown consistent improvements in meaningful aging markers. A 2022 randomized trial by Pencina et al. in Nature Aging found that NMN supplementation raised blood NAD+ levels in older adults, but the downstream effects on muscle function were modest. IV NAD+ specifically has even less controlled trial data than oral precursors.

What did they get wrong (or right)?

She got the side effect experience right. She got the mitochondria link mostly right. The "fountain of youth" framing is wrong, or at least unsupported, and she sort of knows it, which is why she hedges at the end.

The specific phrase "interacting with the mitochondria of your cells" is a reasonable lay explanation. NAD+ is central to the electron transport chain and mitochondrial function. But the infusion side effects are probably more about rapid systemic exposure and activation of purinergic receptors than a direct mitochondrial interaction in real time. Research by Braidy et al. (2019, Antioxidants and Redox Signaling) points to vascular and neural receptor activation as a contributor to the dysphoric sensation, not just mitochondrial uptake.

Where she deserves credit: she didn't claim NAD+ IV cured anything. She didn't recommend a protocol. She reported personal experience with appropriate uncertainty. That's a low bar, but a lot of wellness content doesn't clear it.

• Side effect description: accurate
• Mitochondria explanation: mostly accurate, simplified
• "Fountain of youth" framing: not supported by human trial data
• Sleep and alertness benefits: plausible but anecdotal

What should you actually know?

NAD+ IV therapy is expensive, not well-studied in humans, and the side effects are real. The longevity framing is ahead of the evidence.

If you're considering NAD+ IV infusions, here's what the current evidence actually supports. Oral NAD+ precursors like NMN and NR do raise blood NAD+ levels in humans (Janssens et al., 2022, Cell Reports Medicine). Whether higher blood NAD+ translates into meaningful longevity or performance benefits in otherwise healthy people is not established. IV delivery bypasses gut absorption and raises levels faster, but faster does not mean more effective, and the side effect burden is substantially higher than oral routes.

The infusion cost typically runs $200 to $1,000 per session depending on the clinic, and most people need multiple sessions to notice anything. The sleep and alertness improvements she noticed could reflect placebo response, a rebound effect after the metabolic stress of the infusion, or genuine benefit. Without a control condition, it's impossible to separate these.

NAD+ research is genuinely interesting. The hype around IV delivery specifically is running well ahead of the data. If a clinic is calling this the "fountain of youth," that's a marketing claim, not a clinical one.